Cargando…

Follow-up of Cardiac Fabry Disease Treated by Cardiac Resynchronization Therapy

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Fukuda, Yuko, Onishi, Tetsuari, Suzuki, Atsushi, Tanaka, Hidekazu, Fukuzawa, Koji, Yoshida, Akihiro, Kawai, Hiroya, Hirata, Ken-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	CRT and Fabry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058224/ https://www.ncbi.nlm.nih.gov/pubmed/30062265 http://dx.doi.org/10.1016/j.case.2017.04.004

Ejemplares similares

Strain dyssynchrony index determined by three-dimensional speckle area tracking can predict response to cardiac resynchronization therapy
por: Tatsumi, Kazuhiro, et al.
Publicado: (2011)

Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure
por: Small, Roy S, et al.
Publicado: (2014)

The prevalence and importance of frailty in cardiac resynchronization therapy patients
por: Kuthi, L, et al.
Publicado: (2023)

Epicardial versus endocardial pacing in cardiac resynchronization therapy
por: Marciniak, M, et al.
Publicado: (2023)

What determines who gets cardiac resynchronization therapy in europe?
por: Gatti, P, et al.
Publicado: (2023)

Left-bundle branch block, an alert for cardiac resynchronization therapy
por: Gatti, P, et al.
Publicado: (2023)

Progression of Left Ventricular Fibrosis in a Woman with Anderson-Fabry Disease: Longitudinal Observations Using Two-Dimensional Speckle-Tracking Echocardiography
por: Takase, Yoshiyuki, et al.
Publicado: (2018)

Response to cardiac resynchronization therapy and treatment with ARNi and iSGLT2
por: Fonderico, C, et al.
Publicado: (2023)

Hemodynamic optimization of cardiac resynchronization therapy by heart sound sensor in pulse generator
por: Prinzen, F, et al.
Publicado: (2023)

Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease
por: Fujii, Hideki, et al.
Publicado: (2012)

Predictive value of scar burden assessed by cardiac MRI on sudden cardiac death in cardiac resynchronization therapy patients: a systematic review and meta-analysis
por: Masszi, R, et al.
Publicado: (2023)

Changes in myocardial perfusion according to left ventricular pacing site in cardiac resynchronization therapy
por: Stephansen, C, et al.
Publicado: (2023)

Cardiac resynchronization therapy guided by activation mapping in non-left bundle branch block patients
por: Quesada Ocete, F J, et al.
Publicado: (2023)

Long-term outcome in patients with heart failure and diabetes mellitus treated with cardiac resynchronization therapy
por: Jedrzejczyk-Patej, E, et al.
Publicado: (2023)

Ventricular dyssynchrony assessed by ultra-high-frequency electrocardiography predicts the response to biventricular cardiac resynchronization therapy
por: Leinveber, P, et al.
Publicado: (2023)

Left ventricular global strain and duration of QRS complex as predictors of prognosis after cardiac resynchronization therapy
por: Mashal, A, et al.
Publicado: (2023)

The risk of obesity and the association of body mass index on all-cause mortality after cardiac resynchronization therapy
por: Merkel, E D, et al.
Publicado: (2023)

Baseline creatinine level and long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy
por: Mazurek, M, et al.
Publicado: (2023)

Impact of corticosteroid use on the clinical response and prognosis in patients with cardiac sarcoidosis who underwent an upgrade to cardiac resynchronization therapy
por: Suzuki, Yuya, et al.
Publicado: (2022)

Effects on the timing of left ventricular pressure rise when pacing the right ventricular free wall in cardiac resynchronization therapy
por: Marciniak, M, et al.
Publicado: (2023)

Biventricular or conduction system pacing for cardiac resynchronization therapy: a proposed treatment algorithm based on interventricular conduction delays
por: Carmine Marallo, C M, et al.
Publicado: (2023)

Ventricular arrhythmia events in heart failure patients with cardiac resynchronization therapy with or without a defibrillator for primary prevention
por: Nakamura, Toshihiro, et al.
Publicado: (2022)

Long-term mortality in cardiac resynchronization therapy upgrade procedures compared with de novo implantations - a nationwide cohort study
por: Bjerre, H L, et al.
Publicado: (2023)

Cardiac resynchronization therapy via left bundle branch area pacing and a dual-chamber ICD; a CROSS-LEFT substudy
por: Clementy, N, et al.
Publicado: (2023)

Defibrillator capability and all-cause mortality in patients receiving cardiac resynchronization therapy for non-ischemic cardiomyopathy: a Korean nationwide cohort study
por: Yang, P S, et al.
Publicado: (2023)

Practical guidance for echocardiography for cancer therapeutics-related cardiac dysfunction
por: Onishi, Tetsuari, et al.
Publicado: (2020)

Nonbacterial thrombotic endocarditis associated with cancer of unknown origin complicated with thrombus in the left auricular appendage: case report
por: Norisada, Kazuko, et al.
Publicado: (2011)

Comparison of myocardial depolarization spreading after resynchronization with left bundle branch area pacing versus biventricular pacing
por: Zlahtic, T, et al.
Publicado: (2023)

Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study
por: Tanaka, Hidekazu, et al.
Publicado: (2010)

Ventricular tachycardia based on cardiac sarcoidosis with a narrow QRS complex, ablated on the left ventricle free-wall
por: Imada, Hiroshi, et al.
Publicado: (2021)

Experience managing pain associated with supraclavicular nerves compressed by a cardiac implantable electrical device, diagnosed by the local nerve block
por: Imada, Hiroshi, et al.
Publicado: (2017)

Exercise-induced left bundle branch block and subsequent mechanical left ventricular dyssynchrony -resolved with pharmacological therapy
por: Tanaka, Hidekazu, et al.
Publicado: (2011)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

Managing the patients of heart failure with the data from cardiac MRI and endomyocardial biopsy
por: Taniguchi, Yasuyo, et al.
Publicado: (2015)

Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels
por: Konishi, Hiroki, et al.
Publicado: (2017)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Cardiac Resynchronization Therapy in Children
por: Batra, Anjan S, et al.
Publicado: (2009)

Advances in Cardiac Resynchronization Therapy
por: Jafferani, Asif, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Pediatrics
por: Hill, Allison C., et al.
Publicado: (2018)

Cardiac Resynchronization Therapy Vegetations
por: Hamada, Abdel Haleem Shawky, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_289t6ms1ihmpaqrsiemud35hnc